Close
Back to REGN Stock Lookup

Regeneron (REGN) – FDA

Dec 11, 2023 03:48 AM Regeneron (REGN) Reports New Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes
Nov 27, 2023 05:03 AM Regeneron (REGN) Reports Dupixent Significantly Reduced COPD Exacerbations in Second Positive Phase 3 Trial
Oct 26, 2023 04:01 PM
Oct 5, 2023 09:43 AM
Oct 3, 2023 07:02 AM
Sep 29, 2023 08:31 AM
Sep 20, 2023 09:02 AM
Aug 22, 2023 02:16 PM
Aug 21, 2023 08:02 AM
Aug 21, 2023 06:11 AM
Aug 18, 2023 02:08 PM
Aug 18, 2023 01:45 PM
Aug 17, 2023 08:30 AM
Jun 27, 2023 04:13 PM
Jun 27, 2023 02:59 PM
Jun 27, 2023 02:46 PM
Jun 27, 2023 02:45 PM
May 25, 2023 05:06 PM
May 25, 2023 05:04 PM
Apr 26, 2023 04:05 PM
Mar 29, 2023 07:01 AM
Mar 23, 2023 05:29 AM
Mar 22, 2023 09:44 AM
Mar 22, 2023 07:02 AM
Mar 22, 2023 07:01 AM
Mar 21, 2023 05:47 AM
Mar 21, 2023 05:33 AM
Mar 20, 2023 05:57 AM
Mar 17, 2023 06:32 AM
Mar 1, 2023 05:51 AM
Feb 24, 2023 07:45 AM
Feb 23, 2023 07:06 AM
Feb 21, 2023 07:03 AM
Feb 21, 2023 07:01 AM
Jan 30, 2023 05:51 AM
Jan 27, 2023 05:50 AM
Jan 6, 2023 09:11 AM
Dec 23, 2022 08:31 AM
Dec 22, 2022 05:13 AM
Dec 16, 2022 07:30 AM
Dec 15, 2022 05:47 AM
Dec 12, 2022 10:02 AM
Dec 12, 2022 06:51 AM
Nov 30, 2022 08:06 AM
Nov 22, 2022 07:01 AM
Nov 17, 2022 07:01 AM
Nov 11, 2022 06:59 AM
Nov 9, 2022 12:43 PM
Nov 8, 2022 04:45 PM
Oct 21, 2022 07:00 AM

Back to REGN Stock Lookup